Drug Information

Drug General Information
Drug ID
D09YJT
Former ID
DIB006052
Drug Name
Abilify Maintena
Synonyms
Aripiprazole for extended release
Indication Erythropoietic porphyria [ICD10:E80.0] Approved [551871]
Company
Otsuka pharmaceutical
Target and Pathway
Target(s) 5-hydroxytryptamine 2A receptor Target Info Agonist [526792], [527134]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
PANTHER Pathway 5HT2 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (q) signalling events
WikiPathways Serotonin Receptor 2 and STAT3 Signaling
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
SIDS Susceptibility Pathways
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 526792Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598). J Pharmacol Exp Ther. 1992 Jan;260(1):146-59.
Ref 527134Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs. 2004;64(15):1715-36.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.